scholarly journals Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia

Haematologica ◽  
2013 ◽  
Vol 98 (6) ◽  
pp. 908-912 ◽  
Author(s):  
A. H. Shih ◽  
S. S. Chung ◽  
E. K. Dolezal ◽  
S.-J. Zhang ◽  
O. I. Abdel-Wahab ◽  
...  
Keyword(s):  
Myelodysplastic Syndromes ◽  
Acute Myelogenous Leukemia ◽  
Mutational Analysis ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia

2012 ◽  
Vol 36 (5) ◽  
pp. 570-574 ◽  
Author(s):  
Virginia M. Klimek ◽  
Emily K. Dolezal ◽  
Larry Smith ◽  
Gerald Soff ◽  
Stephen D. Nimer
Keyword(s):  
Phase I ◽  
Myelodysplastic Syndromes ◽  
Acute Myelogenous Leukemia ◽  
Phase I Trial ◽  
Sodium Salicylate ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

scholarly journals Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)

Blood ◽  
2013 ◽  
Vol 122 (11) ◽  
pp. 1974-1982 ◽  
Author(s):  
Wael Saber ◽  
Corey S. Cutler ◽  
Ryotaro Nakamura ◽  
Mei-Jie Zhang ◽  
Ehab Atallah ◽  
...  
Keyword(s):  
Myelodysplastic Syndromes ◽  
Acute Myelogenous Leukemia ◽  
Hematopoietic Cell Transplantation ◽  
Important Determinant ◽  
Myelogenous Leukemia ◽  
Post Transplantation ◽  
Key Points ◽  
Acute Myelogenous ◽  
Transplantation Outcomes ◽  
Donor Source

Key Points For patients with acute myelogenous leukemia, post-transplant survival is not determined by donor source (unrelated vs related). However, for patients with myelodysplastic syndromes, donor source remains an important determinant of post-transplantation outcomes.

scholarly journals Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy

2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
Pradyumna Agasthi ◽  
Hemalatha Narayanasamy ◽  
Dan Sorajja ◽  
James Slack ◽  
Farouk Mookadam
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Chronic Myelogenous Leukemia ◽  
Myelodysplastic Syndromes ◽  
Acute Myelogenous Leukemia ◽  
Hematologic Malignancy ◽  
Myelogenous Leukemia ◽  
Pyrimidine Analogue ◽  
Acute Myelogenous

Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic myelogenous leukemia, and acute myelogenous leukemia. We present a case of cardiomyopathy associated with decitabine used for secondary acute myelogenous leukemia. The patient presented with new heart failure symptoms and an ejection fraction decline.

Sign in / Sign up

Export Citation Format

Share Document